Genotypes of 2579 patients with phenylketonuria reveal a high rate of BH4 non-responders in Russia.
Phenylalanine hydroxylase (PAH) deficiency is responsible for most cases of phenylketonuria (PKU). Furthermore, numerous studies on BH4-sensitive PAH deficiency have been conducted. To date, BH4, a cofactor of PAH, has not been used to treat PKU in Russia.Genotype data of patients with PKU can be us...
Main Authors: | Polina Gundorova, Anna A Stepanova, Irina A Kuznetsova, Sergey I Kutsev, Aleksander V Polyakov |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0211048 |
Similar Items
-
Molecular-genetic causes for the high frequency of phenylketonuria in the population from the North Caucasus.
by: Polina Gundorova, et al.
Published: (2018-01-01) -
Pretreatment cognitive and neural differences between sapropterin dihydrochloride responders and non-responders with phenylketonuria
by: Zoë Hawks, et al.
Published: (2017-09-01) -
Protein Substitute Requirements of Patients with Phenylketonuria on BH4 Treatment: A Systematic Review and Meta-Analysis
by: Fatma Ilgaz, et al.
Published: (2021-03-01) -
One-year follow-up of B vitamin and Iron status in patients with phenylketonuria provided tetrahydrobiopterin (BH4)
by: Kristen D Brantley, et al.
Published: (2018-10-01) -
The challenge of long-term tetrahydrobiopterin (BH4) therapy in phenylketonuria: Effects on metabolic control, nutritional habits and nutrient supply
by: Alena G. Thiele, et al.
Published: (2015-09-01)